Newsroom | Top Stories | Abbott U.S.
WEBJun 26, 2024 — Report Finds Abbott is Most Profitable Healthcare Stock of All Time. Abbott is No. 1 in healthcare and No. 11 overall in an Arizona State University report analyzing long-term returns for publicly traded companies. SEE MORE.
Abbott Receives U.S. FDA Clearance for Two New Over-the …
WEBABBOTT PARK, Ill., June 10, 2024 / PRNewswire / -- Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose monitoring (CGM) systems – Lingo™ and Libre Rio™, which are based on Abbott's world-leading FreeStyle Libre® continuous glucose monitoring …
Abbott MediaRoom - Press Releases
WEBAbbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside. Mar 27, 2024.
Abbott Reports Fourth-Quarter and Full-Year 2023 ... - Abbott …
WEBABBOTT PARK, Ill., Jan. 24, 2024 / PRNewswire / -- Abbott today announced financial results for the fourth quarter ended Dec. 31, 2023. Fourth-quarter sales increased 1.5 percent on a reported basis, 2.1 percent on an organic basis, and 11.0 percent on an organic basis, excluding COVID-19 testing-related sales 1.
After baby formula problems, Abbott Laboratories under DOJ ... - NBC News
WEBJan 21, 2023 — Abbott Laboratories is under investigation by the U.S. Department of Justice, the company confirmed Friday, almost a year after it shut down a Michigan baby-formula plant after illnesses were...
Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, …
WEBApr 17, 2024 — ABT. Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance. Wednesday, Abbott Laboratories (NYSE: ABT) reported first-quarter sales of $9.96 billion, up...
Abbott’s Q4 Earnings Sustain Momentum Into 2024
WEBJan 24, 2024 — Sales for the fourth quarter of 2023 reached $10.2 billion, an 11.0% organic increase, excluding COVID-19 testing-related revenue, driven by Medical Devices (up 15.4% organic; 17.5% reported) and Nutrition (up 13.9% organic; 12.2% reported).
Abbott Laboratories (ABT) Latest Stock News & Headlines
WEBGet the latest Abbott Laboratories (ABT) stock news and headlines to help you in your trading and investing decisions.
Abbott Q4 Earnings: Continued Resiliency | Abbott Newsroom
WEBJan 25, 2023 — Abbott issued full-year guidance for 2023 adjusted diluted EPS from continuing operations of $4.30 to $4.50. 3 These are the key fourth-quarter highlights: Sales of FreeStyle Libre systems exceeded $1 billion with U.S. sales growing more than 40%.
Abbott Laboratories Q2 Earnings: Revenue And Profit Beat …
WEBJul 18, 2024 — On Thursday, Abbott Laboratories (NYSE:ABT) reported second-quarter sales of $10.38 billion, up 4%, almost in line with the consensus of $10.37 billion.